A1 adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice.

Teng, Bunyen; Smith, Jonathan D; Rosenfeld, Michael E; Robinet, Peggy; Davis, Mary E; Morrison, R Ray; Mustafa, S Jamal

A1 adenosine receptor deficiency or inhibition reduces atherosclerotic lesions in apolipoprotein E deficient mice.

Teng, Bunyen; Smith, Jonathan D; Rosenfeld, Michael E; Robinet, Peggy; Davis, Mary E; Morrison, R Ray; Mustafa, S Jamal.

Affiliation

Teng B; Department of Physiology and Pharmacology, Center for Cardiovascular and Respiratory Sciences, West Virginia University, 1 Medical Center Drive, Morgantown, WV, USA.

Cardiovasc Res ; 102(1): 157-65, 2014 Apr 01.

Article in En | MEDLINE | ID: mdl-24525840

Subject(s)

Apolipoproteins E/deficiency; Atherosclerosis/metabolism; Cholesterol/metabolism; Receptor, Adenosine A1/metabolism; Animals; Aorta/metabolism; Disease Models, Animal; Inflammation/metabolism; Macrophages/metabolism; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A1/deficiency

Key words

1,3-Dipropyl-8-cyclopentylxanthine (DPCPX); A1 adenosine receptor; Apolipoprotein E; Cytokines; IL-13

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Apolipoproteins E / Cholesterol / Receptor, Adenosine A1 / Atherosclerosis Limits: Animals Language: En Journal: Cardiovasc Res Year: 2014 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google